Healthcare

Audeara Secures Major $570,000 Purchase Order from Clinico, Shares S...

Key Points:,Clinico, Taiwan’s largest hearing aid retailer, has placed a $570,000 purchase order with Audeara for healthy hearing earbuds.,The earbuds...

Orthocell Secures Key Approval in Singapore for Nerve Repair Product...

Highlights,Orthocell,receives regulatory approval in Singapore for its,Remplir,™ product.,Singapore acts as a gateway to other ASEAN markets for,Ortho...

Lumos Diagnostics Raises A$10 Million for Growth and Expansion

Highlights,Lumos Diagnostics completed a successful fundraising round.,The company raised a total of A$10 million through an entitlement offer.,Funds...

Pro Medicus (ASX:PME) Secures AU$98M, 8-Year Contract Renewal with M...

Key Points:,Pro Medicus' U.S. subsidiary signs an eight-year contract renewal with Mercy Health, valued at A$98 million.,The deal includes Visage 7 Vi...

Orthocell (ASX:OCC) Records Strong Growth in 2024

Highlights,Orthocell,achieved record revenue of A$2.03 million in Q3 2024.,Demand for key products Striate+ and,Remplir,continues to drive growth.,US...

Mesoblast (ASX:MSB) Poised for Breakthrough as FDA Decision Nears

Highlights,Mesoblast shares have risen by 65% in the past month.,FDA approval for its stem-cell therapy,Ryoncil,is expected soon.,Mesoblast is advanci...

Cochlear Limited (ASX:COH) Sees Revised Valuation Amid Market Shifts

Highlights:,Cochlear's,stock declined over 13% after the August results, leading to a,reevaluation,.,Citi analysts have revised the price target for C...

Chimeric Therapeutics (ASX:CHM) Reports Cancer Treatment Breakthroug...

Highlights,Chimeric Therapeutics reports a complete response in a,leukaemia,patient during its latest drug trial.,The combination of ‘CORE-NK’ and,Vac...

Neuren Pharmaceuticals (ASX:NEU) Advances FDA-Approved Phase 3 Trial

Highlights,Neuren,Pharmaceuticals received positive FDA feedback for its Phase 3 trial.,The trial will focus on children with Phelan-McDermid Syndrome...

Nyrada (ASX:NYR) Advances NYR-BI03 Drug with Successful Safety Study

Highlights,Nyrada,completed a safety study for its NYR-BI03 drug candidate.,The drug is being developed to treat stroke and traumatic brain injury (TB...

Immuron (ASX:IMC) Advances Research on Enteric Disease Treatment

Highlights,Immuron,(,ASX:IMC,) supports US military research on a new treatment for enteric diseases.,Interim trial results show limited protective ef...

A Closer Look at Insider Transactions at Aroa Biosurgery (ASX:ARX)

Highlights,Insider directors of Aroa Biosurgery have recently increased their stakes in the company.,Insider purchases have been made at prices higher...

Control Bionics (ASX:CBL) Reports Rising NDIS Approvals and New Leas...

Highlights,Control Bionics sees rising NDIS approvals after delays.,New leasing programs launched for communication devices in Australia.,Rights issue...

Cochlear (ASX:COH) Shares Rebound After Citi Upgrade, Forecasts Stro...

Key Points:,Cochlear's stock rose 1.5% to AU$291.92 after Citi upgraded the stock from "sell" to "neutral.",Citi raised its price target to AU$305, ci...

Lumos Diagnostics Secures Funding for FebriDx® Diagnostic Tool Expan...

Highlights:,Funding Achievement,:,Lumos Diagnostics Holdings Ltd (ASX: LDX, OTC: LDXHF) has secured approximately,US$2,984,571,from BARDA to advance i...

Neurotech International’s FDA Setback: Orphan Drug Status Denied for...

Highlights:,Neurotech International (,ASX:NTI,) was denied orphan drug status by the FDA for NTI164, citing concerns over the rarity of its target con...

CSL Ltd's 2024 Performance and Sector Overview

Highlights,CSL Ltd share price shows slight increase in 2024.,The Healthcare sector offers consistent revenue growth potential.,CSL operates in essent...

Lumos Diagnostics Secures $3M Funding from BARDA for FebriDx FDA Exp...

Highlights,Lumos Diagnostics secures nearly $3 million in funding from BARDA.,The funds will support the FebriDx test’s CLIA waiver study and US FDA a...

Island Pharma Raises $3.5M, Radiopharm Preps US Trial, Truscreen Get...

Highlights,Island Pharmaceuticals raises $3.5M for its dengue fever study.,Radiopharm,Theranostics,prepares for a US cancer trial with FDA support.,Tr...

Cyclopharm Signs Interim Agreement with U.S. Veterans Health Adminis...

Cyclopharm Limited (ASX:CYC) has announced an Interim Agreement (IA) to supply the U.S. Veterans Health Administration (VA) with pharmaceutical and co...